Acute myocardial infarction in man treated with epirubicin for non-Hodgkin lymphoma.
Am J Clin Oncol
; 18(5): 444-8, 1995 Oct.
Article
em En
| MEDLINE
| ID: mdl-7572766
ABSTRACT
This article presents a young patient affected with non-Hodgkin lymphoma who developed acute myocardial infarction 7 days after treatment with epirubicin (90 mg/m2, day 1), cyclophosphamide (600 mg/m2, day 1), vincristine (2 mg, day 1), prednisolone (100 mg, days 1-5), and ondansetron (3 x 4 mg/day, days 1-2). Six months after the myocardial infarction the patient had no further cardiac complications after treatment with cylcophosphamide, vincristine, and ondansetron chemotherapy regimen. Epirubicin was considered to play an important role in the production of infarction, and the probable mechanisms of epirubicin-induced myocardial infarction are discussed.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfoma não Hodgkin
/
Epirubicina
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Infarto do Miocárdio
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Am J Clin Oncol
Ano de publicação:
1995
Tipo de documento:
Article
País de afiliação:
Turquia